CLIMB BIO, INC. Public Float
CLIMB BIO, INC. (CLYM) had Public Float of $44.80 million as of 2025-06-30, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-05
- 2025-06-30: Entity Public Float $44.80M.
- 2024-06-28: Entity Public Float $195.90M.
- 2023-06-30: Entity Public Float $13.20M.
- 2022-06-30: Entity Public Float $13.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $44.80M 10-K · filed 2026-03-05 |
| 2024-06-28 | $195.90M 10-K · filed 2025-03-25 |
| 2023-06-30 | $13.20M 10-K/A · filed 2024-04-29 |
| 2022-06-30 | $13.90M 10-K · filed 2023-03-06 |
| 2021-06-30 | $0.00 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |